

CLASSIFICATION: DUAL GLP-1/GLUCAGON RECEPTOR AGONIST
ACTIVE SUBSTANCE: MAZDUTIDE
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 6-8 DAYS
DOSAGE: 1-2.5 MG ONCE OR TWICE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT COMMON
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
Stealth Labs Mazdutide 10 mg delivers a cutting-edge dual agonist peptide targeting GLP-1 and glucagon receptors. Each 2 mL vial contains 10 mg of Mazdutide, produced under strict research-grade standards to support advanced studies in weight management and metabolic health.
Mazdutide (also known as IBI362) is a novel peptide studied for its dual action on the GLP-1 and glucagon receptors. Research suggests it promotes weight loss, enhances glucose control, increases energy expenditure, and improves lipid profiles in metabolic research models [Clinical Study].
Research protocols typically involve subcutaneous injections administered once or twice weekly, depending on study design. Initial research doses range between 1-2.5 mg per administration. Research use should always be conducted under professional supervision.
For synergistic metabolic research, combine Mazdutide with Cagrilintide from Stealth Labs USA. Discover additional cutting-edge research peptides in the Stealth Labs Peptides category.
Mazdutide is studied for promoting weight loss, improving glucose metabolism, enhancing energy expenditure, and regulating appetite via dual GLP-1 and glucagon receptor activation.
Research typically involves subcutaneous injections of 1-2.5 mg once or twice weekly. Dosage adjustments may vary based on research objectives and subject tolerance.
Clinical studies suggest a favorable safety profile. Possible mild side effects include nausea or gastrointestinal discomfort during initial research stages. Supervision is advised.
Authentic Mazdutide 10 mg by Stealth Labs USA is available in our Stealth Labs USA Peptides catalog, offering premium research peptides.
Please log in to write MAZDUTIDE 10MG review.
CLASSIFICATION: REGENERATIVE PEPTIDE
ACTIVE SUBSTANCE: PENTADECAPEPTIDE
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 4–6 HOURS
DOSAGE: 200–500 MCG DAILY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): NOT REPORTED
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: SEMAGLUTIDE
FORM: 2 ML VIAL (5 MG/VIAL)
ACTIVE HALF-LIFE: ~ 7 DAYS
DOSAGE: 0.25-0.5 MG WEEKLY, TITRATE AS NEEDED
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: GLP-1 RECEPTOR AGONIST
ACTIVE SUBSTANCE: TIRZEPATIDE
FORM: LYOPHILIZED POWDER – 2 ML VIAL (20 MG/VIAL)
ACTIVE HALF-LIFE: ~5 DAYS
DOSAGE: 2.5 - 5 MG/WEEK (RESEARCH USE ONLY)
ACNE: NO
WATER RETENTION: NO
HIGH BLOOD PRESSURE (HBP): NO
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS USA
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: REGENERATIVE PEPTIDE
ACTIVE SUBSTANCE: THYMOSIN BETA 4
FORM: 2 ML VIAL (10 MG/VIAL)
ACTIVE HALF-LIFE: ~ 2–3 HOURS
DOSAGE: 2–5 MG TWICE WEEKLY (LOADING), THEN ONCE WEEKLY
ACNE: NOT REPORTED
WATER RETENTION: NOT REPORTED
HIGH BLOOD PRESSURE (HBP): UNLIKELY
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!
CLASSIFICATION: RECOMBINANT HUMAN GROWTH HORMONE (R-HGH)
ACTIVE SUBSTANCE: SOMATROPIN
FORM: 1 KIT (10 VIALS x 36 IU/VIAL)
ACTIVE HALF-LIFE: ~ 3–4 HOURS
DOSAGE: 2-6 IU DAILY
ACNE: POSSIBLE
WATER RETENTION: POSSIBLE
HIGH BLOOD PRESSURE (HBP): POSSIBLE AT HIGH DOSES
HEPATOTOXICITY: NO
AROMATIZATION: NO
MANUFACTURER: STEALTH LABS
LABORATORY TESTED: VIEW LAB RESULTS
SHIPPED WITHOUT LABEL!